Hints and tips:
...Sandoz confirmed its products had also been affected and said: “As a responsible manufacturer of generics, we take the risk of counterfeiting very seriously....
...According to analysts and sector specialists, among those least expected to survive stands Clariant, the Swiss group spun off from Sandoz when its parent concentrated on drugs....
...The Ratiopharm deal will cement Teva’s position as the world leader in generics, ahead of Novartis’s Sandoz....
...Advent International, which is bidding with Goldman Sachs, is being advised by Bernhard Hampl, a generic drug industry veteran who has worked at Hexal and Sandoz and this year became chairman of Fresenius...
...Nick Haggar, head of commercial operations for Western Europe for Sandoz, says: “Darwin did not just talk about the survival of the fittest, but also those who adapt....
International Edition